Actinium Pharmaceuticals awarded director Steinhart Richard I 62,800 shares at $0 per share on September 2, 2026. For investors, the transaction records 63,116 shares owned afterward and a separate 94,200 derivative securities position, giving the ownership update both Equity and derivative components.

Key Highlights

  • Steinhart Richard I owned 63,116 Actinium Pharmaceuticals shares after the transaction.
  • The director’s post-transaction derivative securities holding was 94,200.
  • Steinhart Richard I was awarded 62,800 Actinium Pharmaceuticals shares on September 2, 2026.

Actinium Pharmaceuticals, Inc. (AMEX: ATNM) awarded Steinhart Richard I 62,800 shares at $0 per share on September 2, 2026. The filing also reports an award of 94,200 derivative securities to Steinhart Richard I on the same date.

Director’s Post-Transaction Holdings

Steinhart Richard I owned 63,116 Actinium Pharmaceuticals shares after the award. The post-transaction derivative securities balance was also 94,200. The records identify Steinhart Richard I as a director of Actinium Pharmaceuticals.